On Tuesday, Pliant Therapeutics Inc (PLRX) stock saw a decline, ending the day at $10.55 which represents a decrease of $-0.66 or -5.89% from the prior close of $11.21. The stock opened at $11.15 and ...
Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to PliantSOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 ...
We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an ...
Pliant Therapeutics' stock initially surged, but has since fallen due to mixed trial results and competitive pressures. Bexotegrast showed promising results in IPF and PSC trials, but dose ...
TV Technology on MSN2mon
Pliant to Showcase New Compact Crewcom Radio Pack at IBC2024Professional intercoms provider Pliant Technologies will highlight its new CRP-C12 Compact Radio Pack at IBC2024, Sept. 13-17 ...
On Tuesday, Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $11.33 which represents a slight increase of $0.01 or 0.09% from the prior close of $11.32. The stock opened at ...
Broadcast intercom systems play a crucial role in coordinating complex productions and ensuring clear communication ... Read ...
Leerink Partners analyst Faisal Khurshid has maintained their bullish stance on PLRX stock, giving a Buy rating on September 13. Faisal ...
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel ...
Pliant Technologies will reveal its new PHS-IEHU Miniature In-ear Headset, among several enhancements to its range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback